Palliative care adapted to specific high-risk patients' needs can reduce emergency room visits, improve overall care and drive down healthcare costs, but the current policy and practice framework presents numerous obstacles to its implementation.
Palliative care adapted to specific high-risk patients' needs can reduce emergency room visits, improve overall care and drive down healthcare costs, but the current policy and practice framework presents numerous obstacles to its implementation, according to a new report from the Journal of Palliative Medicine.
"Much of the intent of these programs is to overcome both the balkanized health system--hospital, outpatient practice, nursing home, assisted living, hospice--and the disconnect between medical disciplines--primary care providers, hospitalists, cardiologists, oncologists, surgeons, and other specialists--that can frustrate and confound patients," wrote Kathleen Unroe, M.D., of the Indiana University, and Diane E. Meier, M.D., of the Center to Advance Palliative Care.
There are two major obstacles to broader implementation of palliative care, according to a blog post from the New York Times. Firstly, it's typically--and incorrectly--equated with hospice/end-of-life care, Meier said. "Hospice is a form of palliative care for people who are dying, but palliative care is not about dying," she told the Times. "It's about living as well as you can for as long as you can."
Read the full story here: http://bit.ly/189ECzx
Source: FierceHealthcare
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More
Navigating Medicare's Part D Subsidy Program to Achieve Value-Based Care
May 26th 2023On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the May 2023 issue of The American Journal of Managed Care® about the impact of low-income subsidies on the uptake and equitable use of expensive orally administered antimyeloma therapy.
Listen
AHN’s Center for Inclusion Health Personalizing Equitable Care Delivery for Marginalized Communities
February 28th 2023On this episode of Managed Care Cast, we speak with Elizabeth Cuevas, MD, division chief of Allegheny Health Network’s (AHN) Center for Inclusion Health, on prevalent health inequities facing marginalized communities and strategies to identify and address these issues.
Listen
FDA Grants Accelerated Approval to Ponatinib Plus Chemotherapy in First-Line Ph+ ALL
March 19th 2024The FDA has granted accelerated approval to ponatinib (Iclusig) plus chemotherapy for the first-line treatment pf Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL).
Read More
6 Blood Biomarkers Identified to Predict CVD Risk in Patients With Rheumatoid Arthritis
March 15th 2024Baseline levels of serum amyloid A, C‐reactive protein, soluble tumor necrosis factor receptor 1, adiponectin, YKL‐40, and osteoprotegerin could be used to predict a rise in arterial inflammation.
Read More